Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
34.56
+1.71 (5.21%)
At close: Dec 5, 2025, 4:00 PM EST
35.23
+0.67 (1.94%)
After-hours: Dec 5, 2025, 7:18 PM EST
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.10 billion as of December 5, 2025. Its market cap has increased by 15.35% in one year.
Market Cap
2.10B
Enterprise Value
1.31B
1-Year Change
15.35%
Ranking
Category
Stock Price
$34.56
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.10B, an increase of 282.09%. That is a compound annual growth rate of 60.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.99B | 28.36% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |